Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Bristol-Myers restructures, updates guidance

BMY announced a restructuring that includes reducing the number of brands in the company's

Read the full 142 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE